George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPeel Hotels Regulatory News (PHO)

  • There is currently no data for PHO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preliminary Results

15 May 2014 07:00

RNS Number : 1355H
Peel Hotels PLC
15 May 2014
 



 

 

 

PEEL HOTELS PLC

 

PRELIMINARY ANNOUNCEMENT

 

 

 

 

 

Derived from audited results for Financial Year Ended 2 February 2014.

 

 

HIGHLIGHTS

 

# Turnover increased 1.8% to £15,509,911 (2013: £15,233,026)

 

# EBITDA increased 16.6% to £1,980,380 (2013: £1,698,060)

 

# Operating Profit up 65.7% to £929,627 (2013: £560,979)

 

# Net debt decreased £656,567

 

# Profit before tax £341,863 (2013: Loss of £97,411)

 

# Earnings per share basic and diluted 2.78p (2013: 0.03p)

 

 

 

'We hope to sustain improvements in EBITDA growth on the back of a slowly recovering market place and this, together with lower finance costs, should transform the profitability of the Group giving us options in terms of reappearing on the Dividend list, increased capital expenditure and further debt repayments'.

 

 

Robert Peel

Chairman

0207 286 6823

 

Press Enquiries

Peel Hunt LLP / Capel Irwin

0207 418 8907

 

 

 

 

 

 

 

 

Review of the business

 

RESULTS

 

The Group achieved a modest improvement in the Financial Year ended 2 February 2014 with hotel revenues increasing by 1.8% to £15,509,911 (2013: £15,233,026). Hotel gross profit before depreciation and Group administration increased 5.3% to £2,538,464 (2013: £2,410,311). EBITDA increased 16.6% to £1,980,380 (2013: £1,698,060).

 

FINANCE

 

As at 2 February 2014 net debt stood at £11,709,734 (2013: £12,366,301) representing loans totalling £11,420,253 (2013:£12,090,770) and an overdraft of £484,496(2013:£392,085) less £195,015 (2013:£116,554) cash at bank. Gearing on Shareholders' funds was 52.2% with interest covered 0.99 times. Net debt decreased by £656,567 compared with the previous year.

It is worth pointing out that, in spite of the onerous fixed interest swap at 5.83% plus margin of 3% on the majority of our debt costing an additional of £352,000 in interest this year alone and in spite of a challenging trading environment, the Group has decreased its net debt by £3,084,836 over the past four financial years.

 

During the year the Group agreed to an extension to its existing bank loan facility with the Royal Bank of Scotland (which was due to expire on 1 June 2014). This agreement extended the loan facility (at the same level of borrowings and repayment terms as previously) until 31 August 2017. This extension provides the Group with greater certainty with regard to its financial structure going forward over the next three years.

 

During the year the £850,000 of unsecured loan notes that bear interest at 7% per annum to Robert Peel and Charles Peel, which were originally due for repayment in 2013, had the repayment date extended to December 2017.

 

Following the expiry of the fixed interest swap on 11 April 2014 Shareholders should note that there will be a substantial decrease in financial costs in 2014/15 and therefore a positive benefit to the profitability of the Group.

 

 

CAPITAL EXPENDITURE

 

£519,328 was spent in the year mainly on the continuing refurbishment of bedrooms at the Bull Hotel, Peterborough, Midland Hotel, Bradford, the Cosmopolitan Hotel, Leeds and the reception hall at the Caledonian Hotel, Newcastle. We have also resurfaced the car park at the Crown and Mitre Hotel, Carlisle. The Automobile Association product and service percentages for each of our hotels continue to improve which is very encouraging.

 

In addition to the capital expenditure a further £576,192 (2013: £557,048) was spent on repairs and renewals which ensures that we continue to improve the quality of our product.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Group Statement of Comprehensive Income

for the year ended 2 February 2014

2014

2013

£

£

Revenue

15,509,911

15,233,026

Cost of sales

(12,971,447)

(12,822,715)

Gross profit

2,538,464

2,410,311

Administration expenses

(558,084)

(712,251)

Depreciation

(1,050,753)

(1,137,081)

Total administration expenses

(1,608,837)

(1,849,332)

Operating profit

929,627

560,979

Finance income

414

318

Finance expense

(932,822)

(961,444)

Fair value movement on derivative

344,644

302,736

Profit/(loss) before tax

341,863

(97,411)

Income tax

47,610

101,563

Profit and total comprehensive income for the period attributable to owners

389,473

4,152

Earnings per share

Basic & diluted (pence)

2.78

0.03

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Group statement of changes in equity

for the years ended 2 February 2014 and 3 February 2013

 

 

 

 

 

 

 

 

 

 

 

 

Year ended 2 February 2014

Share

Capital

Share

premium

account

Profit

and loss

account

Total

£

£

£

£

Balance brought forward at 4 February 2013

1,401,213

9,743,495

10,908,886

22,053,594

Profit and total comprehensive income for the period

-

-

389,473

389,473

Balance at 2 February 2014

1,401,213

9,743,495

11,298,359

22,443,067

 

 

 

 

 

Year ended 3 February 2013

Share

Capital

Share

premium

account

Profit

and loss

account

Total

£

£

£

£

Balance brought forward at 6 February 2012

 

1,401,213

 

9,743,495

10,904,734

22,049,442

Profit and total comprehensive income for the period

 

 

-

-

4,152

4,152

Balance at 3 February 2013

1,401,213

9,743,495

10,908,886

22,053,594

 

 

 

 

Group Balance Sheet

at 2 February 2014

 

 

 

 

 

 

2014

2013

 

 

£

£

Assets

 

 

 

Non-current assets

 

 

 

Property, plant and equipment

 

36,506,121

37,037,546

Deferred tax asset

 

31,813

115,852

 

 

 

Total non-current assets

 

36,537,934

37,153,398

 

 

 

Current assets

 

 

 

Inventories

 

108,670

99,529

Trade and other receivables

 

1,114,703

1,136,554

Cash and cash equivalents

 

195,015

116,554

Total current assets

 

1,418,388

1,352,637

 

 

 

Total assets

 

37,956,322

38,506,035

 

 

 

 

 

 

Equity and liabilities

 

 

 

Equity attributable to owners of the parent

 

 

 

Share capital

 

1,401,213

1,401,213

Share premium

 

9,743,495

9,743,495

Retained earnings

 

11,298,359

10,908,886

Total equity

 

22,443,067

22,053,594

 

 

 

Liabilities

 

 

 

 

 

 

Non-current

 

 

 

Borrowings

 

10,844,199

9,324,716

Deferred tax liabilities

 

982,306

1,182,914

Derivative financial instruments

 

-

71,958

Non-current liabilities

 

11,826,505

10,579,588

 

 

 

Current

 

 

 

Trade and other payables

 

2,383,690

2,231,275

Borrowings

 

1,060,550

3,158,139

Current tax liabilities

 

83,449

51,692

Derivative financial instruments

 

159,061

431,747

Current Liabilities

 

3,686,750

5,872,853

 

 

 

 

 

 

Total liabilities and equity

 

37,956,322

38,506,035

  

Group Cash Flow Statement

for the year ended 2 February 2014

 

 

 

 

 

 

2014

2013

 

£

£

Cash flows from operating activities

Profit for the year

389,473

4,152

Adjustments for:

Financial income

(414)

(318)

Financial expense

932,822

961,444

Fair value movement on derivative

(344,644)

(302,736)

Income tax

(47,610)

(101,563)

Depreciation

1,050,753

1,137,081

Cash flows before changes in working capital and provisions

1,980,380

1,698,060

UK corporation tax (paid)/received

(37,202)

43,941

Decrease in trade and other receivables

14,524

78,609

Increase in trade and other payables

165,423

95,145

(Increase)/decrease in inventories

(9,141)

2,777

Net cash from operating activities

2,113,984

1,918,532

Cash flows from investing activities

Acquisition of property, plant and equipment

(519,328)

(439,308)

Net cash from investing activities

(519,328)

(439,308)

Cash flows from financing activities

Interest paid

(1,042,552)

(1,001,966)

New loans

-

585,000

Loan repayments

(566,054)

(467,889)

Net cash from financing activities

(1,608,606)

(884,855)

Net (decrease)/increase in cash and cash equivalents

(13,950)

594,369

Cash and cash equivalents at the beginning of the period

(275,531)

(869,900)

Cash and cash equivalents at the end of the period

(289,481)

(275,531)

For the purposes of the cash flow statement, cash and cash equivalents comprise:

Cash and bank balances

195,015

116,554

Bank overdrafts

(484,496)

(392,085)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes

(forming part of the financial statements)

 

 

 1 Basis of preparation

 The financial statements, from which this preliminary announcement has been extracted, have been prepared and approved by the Directors in accordance with International Financial Reporting Standards as adopted by the EU ("Adopted IFRSs"). The financial statements have been prepared under the historical cost convention, except for derivative financial instruments which are included at their fair value.The IFRS accounting policies have been applied consistently to all periods presented in these financial statements. The financial statements are presented in sterling. 2 Publication of non-statutory financial statements

 The financial information set out in this preliminary announcement does not constitute statutory accounts as defined in Section 434 and 435 of the Companies Act 2006.The group statement of comprehensive income, the group statement of changes in equity, the group balance sheet and the group cash flow statement have been extracted from the Group's financial statements for the year ended 2 February 2014 upon which the auditors' opinion is unqualified and does not include any statement under section 498(2) or 498(3) of the Companies Act 2006. Those financial statements have not yet been delivered to the Registrar.

 

3 Earnings per share

Basic earnings per share

The calculation of basic earnings per share at 2 February 2014 was based on the profit attributable to ordinary shareholders of £389,473 (2013: £4,152) and a weighted average number of ordinary shares outstanding of 14,012,123 (2013: 14,012,123). No shares were issued in 2014 or 2013.

 

Diluted earnings per share

There were no potentially dilutive options in issue in 2014 and 2013 and consequently there is no difference between basic and diluted earnings per share.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR LLFIEEIISLIS
12
Date   Source Headline
26th Sep 20193:53 pmRNSCancellation of Admission to Trading on AIM
25th Sep 20194:41 pmRNSSecond Price Monitoring Extn
25th Sep 20194:35 pmRNSPrice Monitoring Extension
24th Sep 20195:45 pmRNSPeel Hotels
19th Sep 20194:30 pmRNSResult of AGM
13th Aug 20197:00 amRNSProposed Cancellation and Notice of AGM
6th Aug 20197:00 amRNSPublication of Accounts and Circular
5th Aug 20199:05 amRNSSecond Price Monitoring Extn
5th Aug 20199:00 amRNSPrice Monitoring Extension
5th Aug 20197:30 amRNSRestoration - Peel Hotels Plc
2nd Aug 20195:11 pmRNSFinal Results
29th Jul 20197:30 amRNSSuspension - Peel Hotels Plc
26th Jul 20195:43 pmRNSTemporary Suspension
18th Oct 20187:00 amRNSInterim Results
12th Sep 20183:05 pmRNSResult of AGM
31st Jul 20188:37 amRNSPublication of Report and Accounts
27th Jul 20187:00 amRNSFinal Results
26th Jul 20184:33 pmRNSChange of Registered Office
1st Feb 20189:02 amRNSHolding(s) in Company
27th Oct 20177:00 amRNSInterim Results
20th Sep 20177:00 amRNSRefinancing
23rd Aug 20175:51 pmRNSAGM Results
20th Jul 20177:00 amRNSFinal Results
11th Oct 20167:00 amRNSInterim Results
27th Jul 201610:03 amRNSAppointment of Non-Executive Director
22nd Jul 20169:46 amRNSAppointment of Non-Executive Director
1st Jun 20162:53 pmRNSResult of AGM
10th May 20167:00 amRNSDividend Payment
29th Apr 20167:00 amRNSFinal Results
4th Dec 20157:00 amRNSHolding(s) in Company
30th Sep 20157:00 amRNSInterim Results
18th Aug 201511:59 amRNSForm 8.5 (EPT/RI) - Sinclair IS Pharma PLC
3rd Jun 20154:59 pmRNSAGM Results
7th May 20157:00 amRNSDividend Payment
22nd Apr 20157:00 amRNSFinal Results
9th Oct 20147:00 amRNSInterim Results
1st Jul 20141:52 pmRNSAGM Results
15th May 20147:00 amRNSPreliminary Results
12th Dec 20131:42 pmRNSDirector/PDMR Shareholding
15th Oct 20137:00 amRNSInterim Results
10th Jul 20135:33 pmRNSAGM Results
5th Jun 20137:00 amRNSFinal Results
1st May 20131:22 pmRNSRefinancing
23rd Oct 20127:00 amRNSHalf Yearly Report
19th Oct 20127:00 amRNSDirectorate Change
8th Jun 20127:00 amRNSPreliminary Results
11th Apr 20127:00 amRNSIssue of Loan Notes
12th Oct 20117:00 amRNSInterim Results
29th Jul 201111:15 amRNSForm 8.5 (EPT/RI) - Minerva Plc
26th Jul 201112:03 pmRNSForm 8.5 (EPT/RI) - Holidaybreak Plc
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.